Yamamoto Toshihide
Yao Tokushukai General Hospital, Yao, Japan.
Eur Thyroid J. 2015 Sep;4(3):201-6. doi: 10.1159/000433532. Epub 2015 Jun 25.
Autoimmune thyroid disease (ATD) has been occasionally observed in patients with primary adrenal insufficiency (PAI). In contrast, less than 20 cases of comorbid PAI with ATD have been found in the English literature. One conceivable reason is difficulty in detecting latent PAI.
Information of clinical presentation and diagnostics is sought to facilitate diagnosis of latent PAI.
Latent PAI was pursued in 11 patients among 159 ATD patients. All of them were maintained in a euthyroid state. Except for one patient with nonrheumatic musculoskeletal symptoms, the other patients, who were asymptomatic in their daily lives, presented with recurrent nonspecific gastrointestinal symptoms or fatigue in stress-associated circumstances. Morning cortisol level <303 nmol/l was used as an inclusion criterion. Their basal adrenocorticotropic hormone levels were normal. The adrenal status was examined by a provocation test, either an insulin-induced hypoglycemia test or a 1-μg intravenous corticotrophin test. Eleven patients showed subnormal cortisol response. They were supplemented with hydrocortisone of doses ≤15 mg/day. After a few months of supplementation, PAI was confirmed by another provocation test. Three patients were excluded because of dissociation of two provocation tests.
Comorbid latent PAI with ATD was pursued from the symptoms stated above and proven by two provocation tests; it was found in 5% (8/159) of the patients.
When patients with ATD are troubled by recurrent stress-associated gastrointestinal or constitutional symptoms or nonrheumatic musculoskeletal symptoms which have remained unrelieved by adjustment of thyroid medication, these symptoms may be a manifestation of comorbid latent PAI. It is worth investigating such patients for latent PAI.
自身免疫性甲状腺疾病(ATD)偶尔会在原发性肾上腺皮质功能减退症(PAI)患者中出现。相比之下,英文文献中报道的PAI合并ATD的病例不到20例。一个可能的原因是难以检测出潜在的PAI。
探寻临床表现和诊断信息,以促进对潜在PAI的诊断。
在159例ATD患者中对11例患者进行潜在PAI的排查。所有患者均维持甲状腺功能正常状态。除1例有非风湿性肌肉骨骼症状的患者外,其他患者在日常生活中无症状,在应激相关情况下出现反复的非特异性胃肠道症状或疲劳感。早晨皮质醇水平<303 nmol/L被用作纳入标准。他们的基础促肾上腺皮质激素水平正常。通过激发试验检查肾上腺状态,即胰岛素诱导的低血糖试验或1μg静脉注射促肾上腺皮质激素试验。11例患者的皮质醇反应低于正常水平。他们接受了剂量≤15 mg/天的氢化可的松补充治疗。补充治疗几个月后,通过另一次激发试验确诊为PAI。3例患者因两次激发试验结果不一致而被排除。
从上述症状中排查出ATD合并潜在PAI,并通过两次激发试验得到证实;在5%(8/159)的患者中发现了这种情况。
当ATD患者因反复出现的应激相关胃肠道或全身性症状或非风湿性肌肉骨骼症状而困扰,且甲状腺药物调整后症状仍未缓解时,这些症状可能是合并潜在PAI的表现。对这类患者进行潜在PAI的调查是值得的。